Products

What will AGI do for Besulpamide?

This classification denotes a diuretic with the molecular formula C15H16ClN3O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 048UJ2MM65, chemically known as 1-((4-chloro-3-sulfamoylbenzoyl)amino)-2,4,6-trimethylpyridinium hydroxide, inner salt but generally known as besulpamide, which bears US NIH Compound Identifier 9571085. European Medicines Agency schedules Besulpamide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05789MIG. The term BESULPAMIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 39, No. 5, 1985, List 25). BESULPAMIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule besulpamide under HS 29350090 and SITC 51580. As of Q4 2014, BESULPAMIDE remains the US FDA Preferred Term for this commodity. Besulpamide bears US NLM identifiers UMLS ID C0053356 and NCI Concept Code C74254. SMILES: CLC1C(S(=O)(=O)N)CC(C(=N\[N]2C(CC(CC2C)C)C)\O)CC1.

How AGI delivers it

Four ways AGI delivers for Besulpamide

  • Headless SaaS for Agents

    Give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

    For Besulpamide, give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

  • Services-as-Software

    Get the professional outcome delivered as software, priced on results, not headcount.

    For Besulpamide, get the professional outcome delivered as software, priced on results, not headcount.

Value flow

How Besulpamide connects

measured by

  • Assay Puritymodel
  • Particle Size Distributionmodel
  • Residual Solventmodel